ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
1
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
1
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Third Party Clinical Testing Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-3H15989
Home | Market Reports | Health| Health Foundations & Medical Research
Global Third Party Clinical Testing Market Research Report 2023
BUY CHAPTERS

Global Third Party Clinical Testing Market Research Report 2025

Code: QYRE-Auto-3H15989
Report
May 2025
Pages:98
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
LabCorp
IQVIA
PAREXEL International Corporation
ICON
Charles River Laboratories
Syneos Health
Medpace
WuXi AppTec
KingMed
DIAN DIAGNOSTICS
Adicon Clinical Laboratories
Kindstar
DAAN Gene
Berry Genomics
Frontage Holdings
Centre Testing International
Shanghai Labway Clinical Laboratory
PPD (Pharmaceutical Product Development)

Third Party Clinical Testing Market

The global market for Third Party Clinical Testing was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Third-party clinical testing refers to clinical testing or pathological diagnosis and other services provided by an independent third-party institution with legal personality, independent of medical institutions.These organizations often include third-party medical testing organizations (also known as Independent Clinical Laboratory or ICL). They can provide a variety of clinical testing and pathological diagnostic services, including but not limited to hematology, immunology, biochemistry, microbiology, genomics and pathology.The emergence of these institutions can effectively improve the efficiency and quality of medical diagnosis, while also reducing medical costs and reducing medical burden.
The driving forces for the development of third-party clinical testing mainly include the following aspects:
Social development and the improvement of people"s health awareness: With the development of society and the improvement of people"s living standards, people"s demand for medical services continues to increase, and their requirements for health and safety are also constantly increasing. This makes medical testing and diagnosis more and more important, thus promoting the development of third-party clinical testing.
Continuous advancement of technology and equipment: With the continuous advancement of medical technology and equipment, the accuracy and reliability of clinical testing have been greatly improved. This also enables third-party clinical testing institutions to better provide high-quality and efficient testing services to medical institutions.
Support from policies and regulations: In order to improve the quality and efficiency of medical services, governments and relevant institutions in various countries are actively promoting the development of third-party clinical testing. The support of these policies and regulations provides favorable conditions for the development of third-party clinical testing.
Needs of hospitals and doctors: Hospitals and doctors also need the support of third-party clinical testing agencies. Due to limited medical resources, hospitals and doctors often need to obtain more professional testing services through third-party clinical testing institutions to better provide treatment services to patients.
Increasing market competition: Competition in the third-party clinical testing market is also increasing. More and more companies are joining this field. In order to gain more market share, they need to continuously improve their technology and service levels, thus promoting the development of third-party clinical testing.
This report aims to provide a comprehensive presentation of the global market for Third Party Clinical Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Third Party Clinical Testing.
The Third Party Clinical Testing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Third Party Clinical Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Third Party Clinical Testing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Third Party Clinical Testing Market Report

Report Metric Details
Report Name Third Party Clinical Testing Market
Segment by Type
Segment by Application
  • Personal
  • Enterprise
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Labcorp, IQVIA, PAREXEL International Corporation, ICON Plc, Charles River Laboratories, Syneos Health, PPD (Pharmaceutical Product Development), Medpace, WuXi AppTec, Kingmed, Dian Diagnostics, Adicon Clinical Laboratories, Kindstar, DaAn Gene, Berry Genomics, Frontage Holdings, Centre Testing International, Shanghai Labway Clinical Laboratory
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Third Party Clinical Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Third Party Clinical Testing Market report?

Ans: The main players in the Third Party Clinical Testing Market are Labcorp, IQVIA, PAREXEL International Corporation, ICON Plc, Charles River Laboratories, Syneos Health, PPD (Pharmaceutical Product Development), Medpace, WuXi AppTec, Kingmed, Dian Diagnostics, Adicon Clinical Laboratories, Kindstar, DaAn Gene, Berry Genomics, Frontage Holdings, Centre Testing International, Shanghai Labway Clinical Laboratory

What are the Application segmentation covered in the Third Party Clinical Testing Market report?

Ans: The Applications covered in the Third Party Clinical Testing Market report are Personal, Enterprise

What are the Type segmentation covered in the Third Party Clinical Testing Market report?

Ans: The Types covered in the Third Party Clinical Testing Market report are Biochemical Tests, Immunity Tests, Routine Blood Tests, Others

Recommended Reports

Clinical Testing Services

Medical Equipment Testing

Blood and Immunology Testing

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Third Party Clinical Testing Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Biochemical Tests
1.2.3 Immunity Tests
1.2.4 Routine Blood Tests
1.2.5 Others
1.3 Market by Application
1.3.1 Global Third Party Clinical Testing Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Personal
1.3.3 Enterprise
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Third Party Clinical Testing Market Perspective (2020-2031)
2.2 Global Third Party Clinical Testing Growth Trends by Region
2.2.1 Global Third Party Clinical Testing Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Third Party Clinical Testing Historic Market Size by Region (2020-2025)
2.2.3 Third Party Clinical Testing Forecasted Market Size by Region (2026-2031)
2.3 Third Party Clinical Testing Market Dynamics
2.3.1 Third Party Clinical Testing Industry Trends
2.3.2 Third Party Clinical Testing Market Drivers
2.3.3 Third Party Clinical Testing Market Challenges
2.3.4 Third Party Clinical Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Third Party Clinical Testing Players by Revenue
3.1.1 Global Top Third Party Clinical Testing Players by Revenue (2020-2025)
3.1.2 Global Third Party Clinical Testing Revenue Market Share by Players (2020-2025)
3.2 Global Third Party Clinical Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Third Party Clinical Testing Revenue
3.4 Global Third Party Clinical Testing Market Concentration Ratio
3.4.1 Global Third Party Clinical Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Third Party Clinical Testing Revenue in 2024
3.5 Global Key Players of Third Party Clinical Testing Head office and Area Served
3.6 Global Key Players of Third Party Clinical Testing, Product and Application
3.7 Global Key Players of Third Party Clinical Testing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Third Party Clinical Testing Breakdown Data by Type
4.1 Global Third Party Clinical Testing Historic Market Size by Type (2020-2025)
4.2 Global Third Party Clinical Testing Forecasted Market Size by Type (2026-2031)
5 Third Party Clinical Testing Breakdown Data by Application
5.1 Global Third Party Clinical Testing Historic Market Size by Application (2020-2025)
5.2 Global Third Party Clinical Testing Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Third Party Clinical Testing Market Size (2020-2031)
6.2 North America Third Party Clinical Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Third Party Clinical Testing Market Size by Country (2020-2025)
6.4 North America Third Party Clinical Testing Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Third Party Clinical Testing Market Size (2020-2031)
7.2 Europe Third Party Clinical Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Third Party Clinical Testing Market Size by Country (2020-2025)
7.4 Europe Third Party Clinical Testing Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Third Party Clinical Testing Market Size (2020-2031)
8.2 Asia-Pacific Third Party Clinical Testing Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Third Party Clinical Testing Market Size by Region (2020-2025)
8.4 Asia-Pacific Third Party Clinical Testing Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Third Party Clinical Testing Market Size (2020-2031)
9.2 Latin America Third Party Clinical Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Third Party Clinical Testing Market Size by Country (2020-2025)
9.4 Latin America Third Party Clinical Testing Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Third Party Clinical Testing Market Size (2020-2031)
10.2 Middle East & Africa Third Party Clinical Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Third Party Clinical Testing Market Size by Country (2020-2025)
10.4 Middle East & Africa Third Party Clinical Testing Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Labcorp
11.1.1 Labcorp Company Details
11.1.2 Labcorp Business Overview
11.1.3 Labcorp Third Party Clinical Testing Introduction
11.1.4 Labcorp Revenue in Third Party Clinical Testing Business (2020-2025)
11.1.5 Labcorp Recent Development
11.2 IQVIA
11.2.1 IQVIA Company Details
11.2.2 IQVIA Business Overview
11.2.3 IQVIA Third Party Clinical Testing Introduction
11.2.4 IQVIA Revenue in Third Party Clinical Testing Business (2020-2025)
11.2.5 IQVIA Recent Development
11.3 PAREXEL International Corporation
11.3.1 PAREXEL International Corporation Company Details
11.3.2 PAREXEL International Corporation Business Overview
11.3.3 PAREXEL International Corporation Third Party Clinical Testing Introduction
11.3.4 PAREXEL International Corporation Revenue in Third Party Clinical Testing Business (2020-2025)
11.3.5 PAREXEL International Corporation Recent Development
11.4 ICON Plc
11.4.1 ICON Plc Company Details
11.4.2 ICON Plc Business Overview
11.4.3 ICON Plc Third Party Clinical Testing Introduction
11.4.4 ICON Plc Revenue in Third Party Clinical Testing Business (2020-2025)
11.4.5 ICON Plc Recent Development
11.5 Charles River Laboratories
11.5.1 Charles River Laboratories Company Details
11.5.2 Charles River Laboratories Business Overview
11.5.3 Charles River Laboratories Third Party Clinical Testing Introduction
11.5.4 Charles River Laboratories Revenue in Third Party Clinical Testing Business (2020-2025)
11.5.5 Charles River Laboratories Recent Development
11.6 Syneos Health
11.6.1 Syneos Health Company Details
11.6.2 Syneos Health Business Overview
11.6.3 Syneos Health Third Party Clinical Testing Introduction
11.6.4 Syneos Health Revenue in Third Party Clinical Testing Business (2020-2025)
11.6.5 Syneos Health Recent Development
11.7 PPD (Pharmaceutical Product Development)
11.7.1 PPD (Pharmaceutical Product Development) Company Details
11.7.2 PPD (Pharmaceutical Product Development) Business Overview
11.7.3 PPD (Pharmaceutical Product Development) Third Party Clinical Testing Introduction
11.7.4 PPD (Pharmaceutical Product Development) Revenue in Third Party Clinical Testing Business (2020-2025)
11.7.5 PPD (Pharmaceutical Product Development) Recent Development
11.8 Medpace
11.8.1 Medpace Company Details
11.8.2 Medpace Business Overview
11.8.3 Medpace Third Party Clinical Testing Introduction
11.8.4 Medpace Revenue in Third Party Clinical Testing Business (2020-2025)
11.8.5 Medpace Recent Development
11.9 WuXi AppTec
11.9.1 WuXi AppTec Company Details
11.9.2 WuXi AppTec Business Overview
11.9.3 WuXi AppTec Third Party Clinical Testing Introduction
11.9.4 WuXi AppTec Revenue in Third Party Clinical Testing Business (2020-2025)
11.9.5 WuXi AppTec Recent Development
11.10 Kingmed
11.10.1 Kingmed Company Details
11.10.2 Kingmed Business Overview
11.10.3 Kingmed Third Party Clinical Testing Introduction
11.10.4 Kingmed Revenue in Third Party Clinical Testing Business (2020-2025)
11.10.5 Kingmed Recent Development
11.11 Dian Diagnostics
11.11.1 Dian Diagnostics Company Details
11.11.2 Dian Diagnostics Business Overview
11.11.3 Dian Diagnostics Third Party Clinical Testing Introduction
11.11.4 Dian Diagnostics Revenue in Third Party Clinical Testing Business (2020-2025)
11.11.5 Dian Diagnostics Recent Development
11.12 Adicon Clinical Laboratories
11.12.1 Adicon Clinical Laboratories Company Details
11.12.2 Adicon Clinical Laboratories Business Overview
11.12.3 Adicon Clinical Laboratories Third Party Clinical Testing Introduction
11.12.4 Adicon Clinical Laboratories Revenue in Third Party Clinical Testing Business (2020-2025)
11.12.5 Adicon Clinical Laboratories Recent Development
11.13 Kindstar
11.13.1 Kindstar Company Details
11.13.2 Kindstar Business Overview
11.13.3 Kindstar Third Party Clinical Testing Introduction
11.13.4 Kindstar Revenue in Third Party Clinical Testing Business (2020-2025)
11.13.5 Kindstar Recent Development
11.14 DaAn Gene
11.14.1 DaAn Gene Company Details
11.14.2 DaAn Gene Business Overview
11.14.3 DaAn Gene Third Party Clinical Testing Introduction
11.14.4 DaAn Gene Revenue in Third Party Clinical Testing Business (2020-2025)
11.14.5 DaAn Gene Recent Development
11.15 Berry Genomics
11.15.1 Berry Genomics Company Details
11.15.2 Berry Genomics Business Overview
11.15.3 Berry Genomics Third Party Clinical Testing Introduction
11.15.4 Berry Genomics Revenue in Third Party Clinical Testing Business (2020-2025)
11.15.5 Berry Genomics Recent Development
11.16 Frontage Holdings
11.16.1 Frontage Holdings Company Details
11.16.2 Frontage Holdings Business Overview
11.16.3 Frontage Holdings Third Party Clinical Testing Introduction
11.16.4 Frontage Holdings Revenue in Third Party Clinical Testing Business (2020-2025)
11.16.5 Frontage Holdings Recent Development
11.17 Centre Testing International
11.17.1 Centre Testing International Company Details
11.17.2 Centre Testing International Business Overview
11.17.3 Centre Testing International Third Party Clinical Testing Introduction
11.17.4 Centre Testing International Revenue in Third Party Clinical Testing Business (2020-2025)
11.17.5 Centre Testing International Recent Development
11.18 Shanghai Labway Clinical Laboratory
11.18.1 Shanghai Labway Clinical Laboratory Company Details
11.18.2 Shanghai Labway Clinical Laboratory Business Overview
11.18.3 Shanghai Labway Clinical Laboratory Third Party Clinical Testing Introduction
11.18.4 Shanghai Labway Clinical Laboratory Revenue in Third Party Clinical Testing Business (2020-2025)
11.18.5 Shanghai Labway Clinical Laboratory Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
LabCorp
IQVIA
PAREXEL International Corporation
ICON
Charles River Laboratories
Syneos Health
Medpace
WuXi AppTec
KingMed
DIAN DIAGNOSTICS
Adicon Clinical Laboratories
Kindstar
DAAN Gene
Berry Genomics
Frontage Holdings
Centre Testing International
Shanghai Labway Clinical Laboratory
PPD (Pharmaceutical Product Development)
List of Tables
 Table 1. Global Third Party Clinical Testing Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Biochemical Tests
 Table 3. Key Players of Immunity Tests
 Table 4. Key Players of Routine Blood Tests
 Table 5. Key Players of Others
 Table 6. Global Third Party Clinical Testing Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Third Party Clinical Testing Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global Third Party Clinical Testing Market Size by Region (2020-2025) & (US$ Million)
 Table 9. Global Third Party Clinical Testing Market Share by Region (2020-2025)
 Table 10. Global Third Party Clinical Testing Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 11. Global Third Party Clinical Testing Market Share by Region (2026-2031)
 Table 12. Third Party Clinical Testing Market Trends
 Table 13. Third Party Clinical Testing Market Drivers
 Table 14. Third Party Clinical Testing Market Challenges
 Table 15. Third Party Clinical Testing Market Restraints
 Table 16. Global Third Party Clinical Testing Revenue by Players (2020-2025) & (US$ Million)
 Table 17. Global Third Party Clinical Testing Market Share by Players (2020-2025)
 Table 18. Global Top Third Party Clinical Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Third Party Clinical Testing as of 2024)
 Table 19. Ranking of Global Top Third Party Clinical Testing Companies by Revenue (US$ Million) in 2024
 Table 20. Global 5 Largest Players Market Share by Third Party Clinical Testing Revenue (CR5 and HHI) & (2020-2025)
 Table 21. Global Key Players of Third Party Clinical Testing, Headquarters and Area Served
 Table 22. Global Key Players of Third Party Clinical Testing, Product and Application
 Table 23. Global Key Players of Third Party Clinical Testing, Date of Enter into This Industry
 Table 24. Mergers & Acquisitions, Expansion Plans
 Table 25. Global Third Party Clinical Testing Market Size by Type (2020-2025) & (US$ Million)
 Table 26. Global Third Party Clinical Testing Revenue Market Share by Type (2020-2025)
 Table 27. Global Third Party Clinical Testing Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 28. Global Third Party Clinical Testing Revenue Market Share by Type (2026-2031)
 Table 29. Global Third Party Clinical Testing Market Size by Application (2020-2025) & (US$ Million)
 Table 30. Global Third Party Clinical Testing Revenue Market Share by Application (2020-2025)
 Table 31. Global Third Party Clinical Testing Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 32. Global Third Party Clinical Testing Revenue Market Share by Application (2026-2031)
 Table 33. North America Third Party Clinical Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 34. North America Third Party Clinical Testing Market Size by Country (2020-2025) & (US$ Million)
 Table 35. North America Third Party Clinical Testing Market Size by Country (2026-2031) & (US$ Million)
 Table 36. Europe Third Party Clinical Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 37. Europe Third Party Clinical Testing Market Size by Country (2020-2025) & (US$ Million)
 Table 38. Europe Third Party Clinical Testing Market Size by Country (2026-2031) & (US$ Million)
 Table 39. Asia-Pacific Third Party Clinical Testing Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 40. Asia-Pacific Third Party Clinical Testing Market Size by Region (2020-2025) & (US$ Million)
 Table 41. Asia-Pacific Third Party Clinical Testing Market Size by Region (2026-2031) & (US$ Million)
 Table 42. Latin America Third Party Clinical Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 43. Latin America Third Party Clinical Testing Market Size by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Third Party Clinical Testing Market Size by Country (2026-2031) & (US$ Million)
 Table 45. Middle East & Africa Third Party Clinical Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 46. Middle East & Africa Third Party Clinical Testing Market Size by Country (2020-2025) & (US$ Million)
 Table 47. Middle East & Africa Third Party Clinical Testing Market Size by Country (2026-2031) & (US$ Million)
 Table 48. Labcorp Company Details
 Table 49. Labcorp Business Overview
 Table 50. Labcorp Third Party Clinical Testing Product
 Table 51. Labcorp Revenue in Third Party Clinical Testing Business (2020-2025) & (US$ Million)
 Table 52. Labcorp Recent Development
 Table 53. IQVIA Company Details
 Table 54. IQVIA Business Overview
 Table 55. IQVIA Third Party Clinical Testing Product
 Table 56. IQVIA Revenue in Third Party Clinical Testing Business (2020-2025) & (US$ Million)
 Table 57. IQVIA Recent Development
 Table 58. PAREXEL International Corporation Company Details
 Table 59. PAREXEL International Corporation Business Overview
 Table 60. PAREXEL International Corporation Third Party Clinical Testing Product
 Table 61. PAREXEL International Corporation Revenue in Third Party Clinical Testing Business (2020-2025) & (US$ Million)
 Table 62. PAREXEL International Corporation Recent Development
 Table 63. ICON Plc Company Details
 Table 64. ICON Plc Business Overview
 Table 65. ICON Plc Third Party Clinical Testing Product
 Table 66. ICON Plc Revenue in Third Party Clinical Testing Business (2020-2025) & (US$ Million)
 Table 67. ICON Plc Recent Development
 Table 68. Charles River Laboratories Company Details
 Table 69. Charles River Laboratories Business Overview
 Table 70. Charles River Laboratories Third Party Clinical Testing Product
 Table 71. Charles River Laboratories Revenue in Third Party Clinical Testing Business (2020-2025) & (US$ Million)
 Table 72. Charles River Laboratories Recent Development
 Table 73. Syneos Health Company Details
 Table 74. Syneos Health Business Overview
 Table 75. Syneos Health Third Party Clinical Testing Product
 Table 76. Syneos Health Revenue in Third Party Clinical Testing Business (2020-2025) & (US$ Million)
 Table 77. Syneos Health Recent Development
 Table 78. PPD (Pharmaceutical Product Development) Company Details
 Table 79. PPD (Pharmaceutical Product Development) Business Overview
 Table 80. PPD (Pharmaceutical Product Development) Third Party Clinical Testing Product
 Table 81. PPD (Pharmaceutical Product Development) Revenue in Third Party Clinical Testing Business (2020-2025) & (US$ Million)
 Table 82. PPD (Pharmaceutical Product Development) Recent Development
 Table 83. Medpace Company Details
 Table 84. Medpace Business Overview
 Table 85. Medpace Third Party Clinical Testing Product
 Table 86. Medpace Revenue in Third Party Clinical Testing Business (2020-2025) & (US$ Million)
 Table 87. Medpace Recent Development
 Table 88. WuXi AppTec Company Details
 Table 89. WuXi AppTec Business Overview
 Table 90. WuXi AppTec Third Party Clinical Testing Product
 Table 91. WuXi AppTec Revenue in Third Party Clinical Testing Business (2020-2025) & (US$ Million)
 Table 92. WuXi AppTec Recent Development
 Table 93. Kingmed Company Details
 Table 94. Kingmed Business Overview
 Table 95. Kingmed Third Party Clinical Testing Product
 Table 96. Kingmed Revenue in Third Party Clinical Testing Business (2020-2025) & (US$ Million)
 Table 97. Kingmed Recent Development
 Table 98. Dian Diagnostics Company Details
 Table 99. Dian Diagnostics Business Overview
 Table 100. Dian Diagnostics Third Party Clinical Testing Product
 Table 101. Dian Diagnostics Revenue in Third Party Clinical Testing Business (2020-2025) & (US$ Million)
 Table 102. Dian Diagnostics Recent Development
 Table 103. Adicon Clinical Laboratories Company Details
 Table 104. Adicon Clinical Laboratories Business Overview
 Table 105. Adicon Clinical Laboratories Third Party Clinical Testing Product
 Table 106. Adicon Clinical Laboratories Revenue in Third Party Clinical Testing Business (2020-2025) & (US$ Million)
 Table 107. Adicon Clinical Laboratories Recent Development
 Table 108. Kindstar Company Details
 Table 109. Kindstar Business Overview
 Table 110. Kindstar Third Party Clinical Testing Product
 Table 111. Kindstar Revenue in Third Party Clinical Testing Business (2020-2025) & (US$ Million)
 Table 112. Kindstar Recent Development
 Table 113. DaAn Gene Company Details
 Table 114. DaAn Gene Business Overview
 Table 115. DaAn Gene Third Party Clinical Testing Product
 Table 116. DaAn Gene Revenue in Third Party Clinical Testing Business (2020-2025) & (US$ Million)
 Table 117. DaAn Gene Recent Development
 Table 118. Berry Genomics Company Details
 Table 119. Berry Genomics Business Overview
 Table 120. Berry Genomics Third Party Clinical Testing Product
 Table 121. Berry Genomics Revenue in Third Party Clinical Testing Business (2020-2025) & (US$ Million)
 Table 122. Berry Genomics Recent Development
 Table 123. Frontage Holdings Company Details
 Table 124. Frontage Holdings Business Overview
 Table 125. Frontage Holdings Third Party Clinical Testing Product
 Table 126. Frontage Holdings Revenue in Third Party Clinical Testing Business (2020-2025) & (US$ Million)
 Table 127. Frontage Holdings Recent Development
 Table 128. Centre Testing International Company Details
 Table 129. Centre Testing International Business Overview
 Table 130. Centre Testing International Third Party Clinical Testing Product
 Table 131. Centre Testing International Revenue in Third Party Clinical Testing Business (2020-2025) & (US$ Million)
 Table 132. Centre Testing International Recent Development
 Table 133. Shanghai Labway Clinical Laboratory Company Details
 Table 134. Shanghai Labway Clinical Laboratory Business Overview
 Table 135. Shanghai Labway Clinical Laboratory Third Party Clinical Testing Product
 Table 136. Shanghai Labway Clinical Laboratory Revenue in Third Party Clinical Testing Business (2020-2025) & (US$ Million)
 Table 137. Shanghai Labway Clinical Laboratory Recent Development
 Table 138. Research Programs/Design for This Report
 Table 139. Key Data Information from Secondary Sources
 Table 140. Key Data Information from Primary Sources
 Table 141. Authors List of This Report


List of Figures
 Figure 1. Third Party Clinical Testing Picture
 Figure 2. Global Third Party Clinical Testing Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Third Party Clinical Testing Market Share by Type: 2024 VS 2031
 Figure 4. Biochemical Tests Features
 Figure 5. Immunity Tests Features
 Figure 6. Routine Blood Tests Features
 Figure 7. Others Features
 Figure 8. Global Third Party Clinical Testing Market Size by Application (2020-2031) & (US$ Million)
 Figure 9. Global Third Party Clinical Testing Market Share by Application: 2024 VS 2031
 Figure 10. Personal Case Studies
 Figure 11. Enterprise Case Studies
 Figure 12. Third Party Clinical Testing Report Years Considered
 Figure 13. Global Third Party Clinical Testing Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 14. Global Third Party Clinical Testing Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Third Party Clinical Testing Market Share by Region: 2024 VS 2031
 Figure 16. Global Third Party Clinical Testing Market Share by Players in 2024
 Figure 17. Global Top Third Party Clinical Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Third Party Clinical Testing as of 2024)
 Figure 18. The Top 10 and 5 Players Market Share by Third Party Clinical Testing Revenue in 2024
 Figure 19. North America Third Party Clinical Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 20. North America Third Party Clinical Testing Market Share by Country (2020-2031)
 Figure 21. United States Third Party Clinical Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Canada Third Party Clinical Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Third Party Clinical Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Third Party Clinical Testing Market Share by Country (2020-2031)
 Figure 25. Germany Third Party Clinical Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. France Third Party Clinical Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. U.K. Third Party Clinical Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Italy Third Party Clinical Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Russia Third Party Clinical Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Nordic Countries Third Party Clinical Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Third Party Clinical Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Third Party Clinical Testing Market Share by Region (2020-2031)
 Figure 33. China Third Party Clinical Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Japan Third Party Clinical Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. South Korea Third Party Clinical Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Southeast Asia Third Party Clinical Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. India Third Party Clinical Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Australia Third Party Clinical Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Third Party Clinical Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Third Party Clinical Testing Market Share by Country (2020-2031)
 Figure 41. Mexico Third Party Clinical Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Brazil Third Party Clinical Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Third Party Clinical Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Third Party Clinical Testing Market Share by Country (2020-2031)
 Figure 45. Turkey Third Party Clinical Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Saudi Arabia Third Party Clinical Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. UAE Third Party Clinical Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Labcorp Revenue Growth Rate in Third Party Clinical Testing Business (2020-2025)
 Figure 49. IQVIA Revenue Growth Rate in Third Party Clinical Testing Business (2020-2025)
 Figure 50. PAREXEL International Corporation Revenue Growth Rate in Third Party Clinical Testing Business (2020-2025)
 Figure 51. ICON Plc Revenue Growth Rate in Third Party Clinical Testing Business (2020-2025)
 Figure 52. Charles River Laboratories Revenue Growth Rate in Third Party Clinical Testing Business (2020-2025)
 Figure 53. Syneos Health Revenue Growth Rate in Third Party Clinical Testing Business (2020-2025)
 Figure 54. PPD (Pharmaceutical Product Development) Revenue Growth Rate in Third Party Clinical Testing Business (2020-2025)
 Figure 55. Medpace Revenue Growth Rate in Third Party Clinical Testing Business (2020-2025)
 Figure 56. WuXi AppTec Revenue Growth Rate in Third Party Clinical Testing Business (2020-2025)
 Figure 57. Kingmed Revenue Growth Rate in Third Party Clinical Testing Business (2020-2025)
 Figure 58. Dian Diagnostics Revenue Growth Rate in Third Party Clinical Testing Business (2020-2025)
 Figure 59. Adicon Clinical Laboratories Revenue Growth Rate in Third Party Clinical Testing Business (2020-2025)
 Figure 60. Kindstar Revenue Growth Rate in Third Party Clinical Testing Business (2020-2025)
 Figure 61. DaAn Gene Revenue Growth Rate in Third Party Clinical Testing Business (2020-2025)
 Figure 62. Berry Genomics Revenue Growth Rate in Third Party Clinical Testing Business (2020-2025)
 Figure 63. Frontage Holdings Revenue Growth Rate in Third Party Clinical Testing Business (2020-2025)
 Figure 64. Centre Testing International Revenue Growth Rate in Third Party Clinical Testing Business (2020-2025)
 Figure 65. Shanghai Labway Clinical Laboratory Revenue Growth Rate in Third Party Clinical Testing Business (2020-2025)
 Figure 66. Bottom-up and Top-down Approaches for This Report
 Figure 67. Data Triangulation
 Figure 68. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS

Global Third party Medical Testing Services Market Research Report 2024
Third Party Clinical Laboratory Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Third party Medical Diagnosis Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Third party Pathology Diagnosis Center Market Research Report 2024
Global Third party Medical Institutions Market Research Report 2024
Third party Medical Inspection Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Semiconductor Third party Laboratory Testing Market Research Report 2025
Global The Third Party Medical Imaging Center Market Research Report 2025
Clinical Laboratory Test Market
Global Third party Health Check up Center Market Research Report 2024
Global Skin Care Products Third party Testing Services Market Research Report 2024
Global Third Party Hemodialysis Center Market Research Report 2024
Human Clinical Laboratory Testing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Point of Care Test Market
Laboratory Testing Service Market
COVID 19 Independent Clinical Laboratory ICL Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Clinical Reference Laboratory Services Market
Hematopathology Clinical Laboratory Service Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Third Party IC Testing Service Market Research Report 2025
Global Clinical Biomarker Testing Market Research Report 2024

RELATED REPORTS

Global Stem Cell Therapy for Multiple Sclerosis Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35H13194
Mon Sep 08 00:00:00 UTC 2025

Add to Cart

Global Circulating Tumor Cells and Cancer Stem Cells Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-30P9123
Mon Sep 08 00:00:00 UTC 2025

Add to Cart

Global Stem Cell Umbilical Cord Blood Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Othe-477
Mon Sep 08 00:00:00 UTC 2025

Add to Cart

Global Oncology Information System Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9W6217
Fri Sep 05 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions